The private company that provides health care services at Arizona
state prisons is being sued by an inmate who was exposed to a tainted
hypodermic needle that may have contained Hepatitis or HIV.
Kevin W. Mitchell
filed suit in Maricopa Superior Court last month seeking damages from
Corizon Health Inc. and the state of Arizona. Mitchell’s lawsuit says he
was exposed a tainted needle in early January when he was given an
insulin shot for diabetes.
The lawsuit said Mitchell — who is serving time for burglary charges —
was notified on Jan. 7 of the tainted needle exposure and that he would
be put on a regiment of vaccination and other treatments for Hepatitis
TRURO – Local inmates will soon have information at their fingertips about the three most common types of hepatitis in Canada.
The Hepatitis Outreach Society of Nova Scotia, or HepNS, is stopping at the Nova Institution for Women on Monday, which coincides with World Hepatitis Day.
“What we’ve experienced is that the general public is not very aware of viral hepatitis,” said Carla Densmore, the executive director of HepNS. “What we want to do is make Nova Scotians more aware about how hepatitis can spread and how they can treat it. One of our main messages is that everyone should get tested.”
A significant proportion of inmates at the Saskatchewan Penitentiary
have been diagnosed with hepatitis C, a blood-borne disease that attacks
The data, provided to paNOW by the Correctional
Service of Canada (CSC) via a Freedom of Information request, shows that
over a six-year period, from 2007 to 2012, between 180 to about 260
inmates had hepatitis C infections.
For a total prison population
that often sits at more than 800 inmates, the numbers show that about
25 per cent of those incarcerated at the Saskatchewan Penitentiary are
affected by hepatitis C.
Inmates in New South Wales, Australia, were prone to developing hepatitis C virus infection through various means of transmission while incarcerated, according to new study data.
Fabio Luciani, PhD, Inflammation and Infection Research Center, School of Medical Sciences, the University of New South Wales, and colleagues enrolled 210 inmates (mean age, 27 years; 73.8% men) from 19 correctional institutions in the Hepatitis C Incidence and Transmission Study in prisons. Only inmates who were negative for hepatitis C virus (HCV)-RNA and antibody-negative at enrollment were included.
“The findings highlight the many challenges remaining in establishing
effective prevention strategies for HCV infection in the prison context,
given the crowded conditions, uncontrolled exposure to violence and
illicit drugs, separation from family networks and emotional
deprivation,” the researchers concluded. “Ongoing surveillance of risk
behaviors and infection rates, and further research to inform the
effectiveness of HCV prevention measures in prisons, are warranted.”
Since 2003, Pennsylvania has screened everyone entering prison for
hepatitis C unless an inmate chooses to opt out of the test. Of the more
than 100,000 people who were tested upon entry between 2004 and 2012,
about 18 percent tested positive for the virus.
“It’s an incredibly high rate,” said lead author, Sarah Larney,
who’s a fellow at the National Drug and Alcohol Research Center at the
University of South Wales and a research associate at Brown University.